- Investing Ideas
- /
- Real Estate Healthcare Sector
Real Estate Healthcare Sector
Results
2308
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,308 companies
OptimizeRx
Market Cap: US$225.6m
A digital health technology company, engages in the provision of tech-enabled marketing solutions for life sciences organizations, healthcare providers, and patients.
OPRX
US$11.95
7D
8.5%
1Y
-7.3%
Monopar Therapeutics
Market Cap: US$225.6m
A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.
MNPR
US$36.90
7D
9.1%
1Y
1,107.7%
Acelyrin
Market Cap: US$225.1m
A clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
SLRN
US$2.27
7D
8.6%
1Y
-47.6%
Ocugen
Market Cap: US$224.8m
A biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.
OCGN
US$0.81
7D
15.3%
1Y
-56.2%
Solid Biosciences
Market Cap: US$224.8m
Develops therapies for neuromuscular and cardiac diseases in the United States.
SLDB
US$2.95
7D
5.7%
1Y
-65.3%
Astria Therapeutics
Market Cap: US$223.5m
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.
ATXS
US$4.26
7D
-2.5%
1Y
-55.6%
MediWound
Market Cap: US$221.3m
A biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally.
MDWD
US$20.51
7D
10.0%
1Y
18.3%
Tenax Therapeutics
Market Cap: US$215.8m
A clinical-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States.
TENX
US$6.00
7D
5.8%
1Y
63.5%
Medical Facilities
Market Cap: CA$298.8m
Through its subsidiaries, owns and operates specialty surgical hospitals and ambulatory surgery center in the United States.
DR
CA$15.66
7D
0.6%
1Y
31.9%
Born
Market Cap: US$213.6m
Does not have significant operations.
BRRN
US$0.47
7D
88.0%
1Y
n/a
Dimerix
Market Cap: AU$329.8m
A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.
DXB
AU$0.57
7D
-4.2%
1Y
65.2%
Performant Healthcare
Market Cap: US$211.4m
Provides audit, recovery, and analytics services in the United States.
PHLT
US$2.68
7D
3.9%
1Y
-12.7%
Fennec Pharmaceuticals
Market Cap: US$211.3m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$8.17
7D
26.1%
1Y
14.7%
AirSculpt Technologies
Market Cap: US$209.8m
Focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom.
AIRS
US$3.56
7D
7.6%
1Y
-17.4%
Tevogen Bio Holdings
Market Cap: US$207.8m
A clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.
TVGN
US$1.15
7D
-3.4%
1Y
47.4%
VitaSpring Biomedical
Market Cap: US$207.0m
Focuses on the development of drugs of cell medicine.
VSBC
US$1.00
7D
0%
1Y
n/a
Silence Therapeutics
Market Cap: US$206.4m
A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.
SLN
US$4.96
7D
29.5%
1Y
-78.8%
Actuate Therapeutics
Market Cap: US$206.1m
A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.
ACTU
US$10.26
7D
-1.8%
1Y
n/a
Integrated Diagnostics Holdings
Market Cap: US$203.5m
Operates as a consumer healthcare company that provides medical diagnostics services to patients.
IDHC
US$0.36
7D
2.9%
1Y
12.5%
Perspective Therapeutics
Market Cap: US$202.6m
Develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States.
CATX
US$2.83
7D
11.0%
1Y
-82.2%
Lexicon Pharmaceuticals
Market Cap: US$201.9m
A biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease.
LXRX
US$0.57
7D
-9.5%
1Y
-65.9%
Codexis
Market Cap: US$201.3m
Provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.
CDXS
US$2.45
7D
-4.3%
1Y
-30.2%
biote
Market Cap: US$201.0m
Operates in practice-building business within the hormone optimization space.
BTMD
US$4.06
7D
1.8%
1Y
-28.0%
Design Therapeutics
Market Cap: US$200.4m
A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.
DSGN
US$3.67
7D
2.8%
1Y
-11.4%
BioStem Technologies
Market Cap: US$199.9m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$12.02
7D
-4.8%
1Y
55.2%
enGene Holdings
Market Cap: US$199.3m
Through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer.
ENGN
US$4.20
7D
45.8%
1Y
-68.3%
OraSure Technologies
Market Cap: US$196.7m
Develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally.
OSUR
US$2.80
7D
5.7%
1Y
-42.9%
Orthocell
Market Cap: AU$304.9m
A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union.
OCC
AU$1.26
7D
-4.9%
1Y
236.0%
Bioventix
Market Cap: UK£145.0m
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
BVXP
UK£29.50
7D
2.6%
1Y
-32.6%
Cardiff Oncology
Market Cap: US$193.6m
A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers.
CRDF
US$3.07
7D
12.9%
1Y
-13.3%
High Tide
Market Cap: CA$269.5m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.26
7D
2.2%
1Y
-0.3%
OmniAb
Market Cap: US$193.3m
A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.
OABI
US$1.55
7D
8.4%
1Y
-64.7%
ME Therapeutics Holdings
Market Cap: CA$269.8m
A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.
METX
CA$10.30
7D
0%
1Y
150.6%
4basebio
Market Cap: UK£144.1m
Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally.
4BB
UK£11.25
7D
0%
1Y
-19.9%
SOPHiA GENETICS
Market Cap: US$191.1m
Operates as a cloud-native software technology company in the healthcare space.
SOPH
US$2.88
7D
-7.7%
1Y
-37.9%
Voyager Therapeutics
Market Cap: US$189.8m
A biotechnology company, focuses on the human genetics for the cure of neurological diseases.
VYGR
US$3.40
7D
3.7%
1Y
-59.7%